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lung cancer and esophageal cancer have focused on
preoperative evaluation, multidisciplinary evaluation and
management, operative technique, and immediate perioper-
ative management.1,2 It has become increasingly clear,
however, that longer-term postoperative management
also has a significant influence on operative results.3-5
Bryant and colleagues6 have previously reported that the in-
terval mortality between 30 days and 90 days is approxi-
mately equal to the 30-day mortality after pulmonary
resection, challenging the definition of ‘‘operative mortal-
ity’’ and emphasizing the importance of continued postop-
erative care throughout at least the first 3 months after
surgery.
In this issue of the Journal, Pezzi and colleagues3 demon-
strate an even larger difference between 30-day and 90-day
mortality. This study analyzed major lung resection from
2007 to 2011 in the National Cancer Database. Among
124,418 patients who underwent major lung resection, the
30-day morality was 2.8% and the 90-day morality was
5.4%, nearly twice as high. Important factors that predicted
mortality include age, stage, extent of resection, and other
medical comorbidities. Although none of these factors
can be altered with the intent of improving mortality, under-
standing the risk factors involved would allow the develop-
ment of risk models to better predict complications and
focus resources on the patients who need them the most.
In addition, with this information it is possible for surgeons
and hospitals to benchmark results, which may be most
important for hospitals with low operative volume. Pezzi
and colleagues3 focus too much attention on hospital vol-
ume, whereas systematic improvements in patient moni-
toring and care could be just as successful in low-volume
hospitals as in high-volume hospitals.
It thus appears that the identification of risk factors that
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tive outcomes. Also in this issue of the Journal, Hu and
coworkers4 demonstrate that readmission after lung cancer
resection is associated with a 6-fold increase in mortality,
further illustrating the importance of postoperative care at
least through the first 3 months after surgery. In this study,
Hu and coworkers4 analyze the Surveillance, Epidemi-
ology and End Results–Medicare registry from 2006 to
2011. The 30-day readmission rate was 12.8%, and among
readmitted patients the 90-day mortality was 14.4%, 6
times the baseline mortality of 2.5%. Of note, the rate
of readmission was significantly associated with age and
extent of procedure, among other factors, allowing inves-
tigators to develop a risk model to predict readmission
with the intent of focusing attention and resources on
the patients who are most likely to readmitted, as articu-
lated in the article. Because the study is based on a Medi-
care administrative database, it excludes patients younger
than 65 years, and various clinical factors that affect deci-
sion making regarding discharge and readmission are not
included. Most importantly, the study is limited in its abil-
ity to identify which readmissions are preventable and
which patients, once readmitted, can be treated success-
fully, although it is thought that the majority of surgical
readmissions are not preventable.7,8
Once patients with lung cancer survive through 90 days,
the management focuses on cancer-specific surveillance.1
There is significant controversy regarding the frequency
of follow-up, whether surveillance should include other
modalities other than interval history and physical exami-
nation, and the use of radiographic surveillance. In this
issue, Crabtree and colleagues5 report their study of the
use of computed tomography (CT) versus chest radiog-
raphy (CXR) in a single-institution series of 554 patients
who underwent resection for stage I lung cancer from
2001 through 2013. In this series, there was no difference
in 5-year survival or detection of successive malignancies
whether radiographic surveillance included CXR or CT.
Although the study may inform clinicians regarding the
utility of CT scanning after resection for stage I lung can-
cer, one should exercise caution before implementing
broad changes in practice. The study did not control for
how it was decided to use CT or CXR, and the authors
cannot exclude selection bias among the subsets of stage
I disease that do not have equivalent survival. Also, the
study does not address other potential benefits of CT sur-
veillance in a patient population with a significant inci-
dence of coronary artery and vascular disease.9 Finally,
as CT scans improve from generation to generation, the
differences in cost and exposure are decreasing, narrowinggery c November 2014
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reasonable to use only CXR for selected patients in whom
oncologic reintervention is less likely to monitor for issues
that would require palliative intervention, such as pneumo-
thorax, pleural effusion, and pericardial effusion.SUMMARY
Although much is known regarding the importance of
postoperative care, the surveillance of patients after 30
days from the surgical procedure can be improved. It
must be recognized that mortality between 30 and 90 days
exceeds what is commonly considered ‘‘operative mortal-
ity’’—death within 30 days of surgery. Significant effort
should be dedicated to the design of predictive models to
prevent readmission. More importantly, surgeons must
develop better models to manage the complications that
arise after readmission to prevent mortality in readmitted
patients. Finally, current guidelines for oncologic surveil-
lance are an area of controversy, and future studies are
needed for better direction of resources.The Journal of Thoracic and CarReferences
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